2.63 USD
↘ 0.03 (1.13%)LIVE (AS OF 10:12 AM EDT)
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOTNASDAQ • USD
Market: OPEN
Shares of BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) are trading at $2.63. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BBOT is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 23, 2026.
Open?$2.66
High?$2.72
Low?$2.61
Prev. Close?$2.66
Volume?26.2K
Avg. Volume?624.0K
VWAP?$2.63
Rel. Volume?0.04x
Bid / Ask
Bid?$2.59 × 1.3K
Ask?$3.05 × 100
Spread?$0.46
Midpoint?$2.82
Valuation & Ratios
Market Cap?213.3M
Shares Out?N/A
Float?27.7M
Float %?34.5%
P/E Ratio?N/A
P/B Ratio?0.66
EPS?-$2.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Employees
88
Market Cap
213.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-08-12
Address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?50
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.44Distress
Confidence?29%Very Low
Short InterestHigh
Short % of Float?12.19%High
Short Interest?3.4M
Days to Cover?5.4
Free Float27.7M
Avg Daily Volume624.7K
Settlement Date2026-09-30
Financial Health
Current Ratio?4.69Strong
Quick Ratio?4.69Strong
Cash Ratio?1.05Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.66CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-56.4%WEAK▾
S&P3
ROA?-48.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-193815454
Enterprise Value?$159.2M
Fundamentals ratios updated end of day